Cargando…
Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis
Drug-induced hepatitis (DIH), which seriously interferes with disease treatment, is one of the most common reasons for termination of new drugs during preclinical studies or post-marketing surveillance. Although antioxidants and anti-inflammatory agents are promising, their nonspecific distribution...
Autores principales: | Zhang, Qixiong, Li, Shanshan, Cai, Lulu, Zhu, Yuxuan, Duan, Xingmei, Jiang, Peidu, Zhong, Lei, Guo, Kun, Tong, Rongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344015/ https://www.ncbi.nlm.nih.gov/pubmed/34373743 http://dx.doi.org/10.7150/thno.61214 |
Ejemplares similares
-
Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis: Erratum
por: Zhang, Qixiong, et al.
Publicado: (2022) -
Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs
por: Lee, Bong-Seop, et al.
Publicado: (2011) -
An orthogonally activatable CRISPR-Cas13d nanoprodrug to reverse chemoresistance for enhanced chemo-photodynamic therapy
por: Liu, Zheng, et al.
Publicado: (2023) -
Hydrophilic Fluorescent Nanoprodrug of Paclitaxel
for Glioblastoma Chemotherapy
por: Daniel, Jonathan, et al.
Publicado: (2019) -
Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy
por: Li, Zekun, et al.
Publicado: (2022)